-
DMD Boys Show Improvements on Edasalonexent in Phase 1/2 Trial
Treatment with edasalonexent enabled normal growth, preserved muscle function, and slowed disease progression in DMD boys, a Phase 1/2 trial shows. Read more about this trial here.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.